| 英文名 | Naltriben |
|---|---|
| 英文别名 |
17-(Cyclopropylmethyl)-6,7-didehydro-,5alpha-oxy-14beta-dihydroxy-6,',3'-benzo[b]furanomorphinan mesylate
NALTRIBEN METHANESULFONATE C26H25NO4 17-(Cyclopropylmethyl)-6,7-didehydro-3,14β-dihydroxy-4,5α-oxy-6,',3'-benzo[b]furanomorphinanmesylate 17-(Cyclopropylmethyl)-6,7-didehydro-3,14b-dihydroxy-4,5a-oxy-6,',3'-benzo[b]furanomorphinanmesylate naltrindolebenzofuran 17-(CYCLOPROPYLMETHYL)-6,7-DIDEHYDRO-3, 14B-DIHYDROXY-4,5A-OXY-6,',3'-BENZO[B]FURANOMORPHINAN MESYLATE 4,8-Methano-8aH-bisbenzofuro[3,2-e:2',3'-g]isoquinoline-1,8a-diol, 7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-, (4bS,8R,8aS,14bR) NTB naltrindole benzofuran HMS2089G18 |
| 描述 | Naltriben 是一种选择性的 δ2-opioid 受体拮抗剂和 TRPM7 激活剂。Naltriben 能增强胶质母细胞瘤细胞的迁移和侵袭。Naltriben 可用于神经系统疾病和癌症的研究。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.5 g/cm3 |
|---|---|
| 沸点 | 605.3ºC at 760 mmHg |
| 分子式 | C26H25NO4 |
| 分子量 | 415.48 |
| 闪点 | 319.9ºC |
| 精确质量 | 511.16600 |
| PSA | 128.82000 |
| LogP | 4.36020 |
| 外观性状 | 灰白色固体 |
| 蒸汽压 | 1.67E-15mmHg at 25°C |
| 折射率 | 1.779 |
|
~81%
111555-58-9 |
| 文献:Portoghese; Sultana; Nagase; Takemori Journal of Medicinal Chemistry, 1988 , vol. 31, # 2 p. 281 - 282 |
|
~%
111555-58-9 |
| 文献:PROGENICS PHARMACEUTICALS, INC Patent: WO2009/67275 A1, 2009 ; Location in patent: Page/Page column 140-141 ; WO 2009/067275 A2 |
| 上游产品 3 | |
|---|---|
| 下游产品 0 | |